GlassScriptPhysician profile
Philip J Lee
NPI 1356907661
$6,178.13
in general payments reported to CMS, 2019-2025
7 companies · $1,905 in 2025
The $1,905 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,047 · 2024: $3,227 · 2025: $1,905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,216 · Food and Beverage: $1,450 · Consulting Fee: $1,225 · Education: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,215.74 |
| Food and Beverage | $1,449.97 |
| Consulting Fee | $1,225.00 |
| Education | $287.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,853.57 | 2024-2025 | Infinity |
| Medtronic, INC. | $1,749.97 | 2023-2025 | Percept PC Brainsense |
| Amneal Pharmaceuticals LLC | $1,225.00 | 2025 | Crexont |
| Boston Scientific Corporation | $822.58 | 2024-2025 | Vercise, Watchman Flx |
| Abbvie INC. | $246.70 | 2024-2025 | |
| Merz Pharmaceuticals, LLC | $192.82 | 2024-2025 | Xeomin, Inbrija |
| Teva Pharmaceuticals USA, INC. | $87.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.